These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9255101)

  • 21. Low-dose hormone replacement therapy for hot flashes.
    Mikhail N
    Mayo Clin Proc; 2003 Mar; 78(3):379; author reply 379. PubMed ID: 12630592
    [No Abstract]   [Full Text] [Related]  

  • 22. Commentary on "menopausal hormone treatment in postmenopausal women: risks and benefits".
    Archer DF
    South Med J; 2014 Nov; 107(11):696-7. PubMed ID: 25365436
    [No Abstract]   [Full Text] [Related]  

  • 23. IMS updates its recommendations on the use of HRT.
    Brown S
    Menopause Int; 2013 Sep; 19(3):105-6. PubMed ID: 24195130
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects on haemostasis of hormone replacement therapy with transdermal estradiol and oral sequential medroxyprogesterone acetate: a 1-year, double-blind, placebo-controlled study. The Writing Group for the Estradiol Clotting Factors Study.
    Thromb Haemost; 1996 Mar; 75(3):476-80. PubMed ID: 8701411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of hormone replacement therapy on clinical fractures and height loss: The Heart and Estrogen/Progestin Replacement Study (HERS).
    Cauley JA; Black DM; Barrett-Connor E; Harris F; Shields K; Applegate W; Cummings SR
    Am J Med; 2001 Apr; 110(6):442-50. PubMed ID: 11331055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does estrogen/progestin therapy in post-menopausal women decrease their risk of fracture?
    Groh KW; Stevermer JJ
    J Fam Pract; 2001 Nov; 50(11):926. PubMed ID: 11711004
    [No Abstract]   [Full Text] [Related]  

  • 27. The influence of transdermal oestradiol replacement therapy and medroxyprogesterone acetate on serum lipids and lipoproteins.
    Bhathena RK; Anklesaria BS; Ganatra AM; Pinto R
    Br J Clin Pharmacol; 1998 Feb; 45(2):170-2. PubMed ID: 9491833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in the lipoprotein profile in postmenopausal women receiving hormone replacement therapy. Effects of natural and synthetic progesterone.
    Chen FP; Lee N; Soong YK
    J Reprod Med; 1998 Jul; 43(7):568-74. PubMed ID: 9693406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone response to treatment with lower doses of conjugated estrogens with and without medroxyprogesterone acetate in early postmenopausal women.
    Lindsay R; Gallagher JC; Kleerekoper M; Pickar JH
    Osteoporos Int; 2005 Apr; 16(4):372-9. PubMed ID: 15654581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of postmenopausal hormone therapy on glucose and insulin concentrations. PEPI Investigators. Postmenopausal Estrogen/Progestin Interventions.
    Espeland MA; Hogan PE; Fineberg SE; Howard G; Schrott H; Waclawiw MA; Bush TL
    Diabetes Care; 1998 Oct; 21(10):1589-95. PubMed ID: 9773716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormone replacement therapy: current controversies.
    Orija IB; Mehta A
    Clin Endocrinol (Oxf); 2003 Nov; 59(5):657. PubMed ID: 14616894
    [No Abstract]   [Full Text] [Related]  

  • 32. A randomized controlled trial of estrogen replacement therapy in long-term users of depot medroxyprogesterone acetate.
    Cundy T; Ames R; Horne A; Clearwater J; Roberts H; Gamble G; Reid IR
    J Clin Endocrinol Metab; 2003 Jan; 88(1):78-81. PubMed ID: 12519833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of transdermal estrogen replacement therapy on hyperandrogenicity and glucose homeostasis in postmenopausal women with NIDDM.
    Andersson B; Mattsson LA
    Acta Obstet Gynecol Scand; 1999 Mar; 78(3):260-1. PubMed ID: 10078591
    [No Abstract]   [Full Text] [Related]  

  • 34. Optimizing continuous-combined hormone replacement therapy for postmenopausal women: a comparison of six different treatment regimens.
    Heikkinen JE; Vaheri RT; Ahomäki SM; Kainulainen PM; Viitanen AT; Timonen UM
    Am J Obstet Gynecol; 2000 Mar; 182(3):560-7. PubMed ID: 10739508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Double-blind method of the effect of menopause symptoms, lipid profile, and endometrial thickness of continuous therapy with estradiol valerate and medroxyprogesterone acetate].
    Blümel JE; Roncagliolo ME; Gramegna G; Vásquez R; Estartus A; Tacla X; Brandt A
    Rev Chil Obstet Ginecol; 1994; 59(5):354-60. PubMed ID: 7569150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Added effect of progestogens on bone mineral density response to oestrogen.
    Evans SF; Davie M
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):123-4. PubMed ID: 8796150
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of estrogen plus progestin on risk of dementia.
    Brinton RD; Nilsen J
    JAMA; 2003 Oct; 290(13):1706; author reply 1707-8. PubMed ID: 14519699
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women.
    Walsh BW; Kuller LH; Wild RA; Paul S; Farmer M; Lawrence JB; Shah AS; Anderson PW
    JAMA; 1998 May; 279(18):1445-51. PubMed ID: 9600478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medical treatment of endometriosis.
    Moghissi KS
    Clin Obstet Gynecol; 1999 Sep; 42(3):620-32. PubMed ID: 10451774
    [No Abstract]   [Full Text] [Related]  

  • 40. Contrasting effects of two hormone replacement therapies on the cardiovascular and mammary gland outcomes in surgically postmenopausal monkeys.
    Suparto IH; Williams JK; Cline JM; Anthony MS; Fox JL
    Am J Obstet Gynecol; 2003 May; 188(5):1132-40. PubMed ID: 12748457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.